MBX Biosciences, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $0Mn |
Net Profits | $-37.1Mn |
Net Profit Margins | -Inf% |
MBX Biosciences, Inc. Common Stock’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2026. On a quarterly growth basis, MBX Biosciences, Inc. Common Stock has generated NaN% jump in its revenue since last 3-months.
MBX Biosciences, Inc. Common Stock’s net profit fell -91.1% since last year same period to $-37.1Mn in the Q2 2026. On a quarterly growth basis, MBX Biosciences, Inc. Common Stock has generated -57.74% fall in its net profits since last 3-months.
MBX Biosciences, Inc. Common Stock’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2026. On a quarterly growth basis, MBX Biosciences, Inc. Common Stock has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.78 |
EPS Estimate Current Year | -0.78 |
MBX Biosciences, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.78 - a -14.71% fall from last quarter’s estimates.
MBX Biosciences, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -0.78.
Key Ratios
Earning Per Share (EPS) | -0.78 |
MBX Biosciences, Inc. Common Stock’s earning per share (EPS) fell -34.48% since last year same period to -0.78 in the Q2 2026. This indicates that the MBX Biosciences, Inc. Common Stock has generated -34.48% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-08-06 | -0.68 | -0.78 | -14.71% |
2026-05-07 | -0.58 | -0.51 | 12.07% |
